Here we reported a case of anti‐MDA5 antibody‐positive DM‐ILD patients who were treated with hormones and immunosuppressive agents in combination with tofacitinib and had negative anti‐MDA5 antibodies, which is summarized below for clinical reference. Here, IFIH1 is linked to interstitial lung disease.